167.00 -0.74 (-0.44%)
Pre-Market: 8:45AM EDT
|Bid||166.51 x 800|
|Ask||167.74 x 800|
|Day's Range||166.24 - 167.88|
|52 Week Range||133.65 - 173.65|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||29.63|
|Earnings Date||Jul. 21, 2021|
|Forward Dividend & Yield||4.24 (2.54%)|
|Ex-Dividend Date||May 24, 2021|
|1y Target Est||186.80|
The cost of vaccines is a mighty bargain compared with the cost of the pandemic.
Dr. Oni Blackstock, Health Justice Founder & Executive Director, joined Yahoo Finance to discuss the latest on covid-19.
Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources. Europe's drug regulator approved J&J's vaccine last month after examining cases of a rare blood clotting issue in U.S. adults who received a dose. A spokeswoman for the Robert Koch Institute (RKI) for infectious diseases said the institute expects STIKO to make a recommendation on J&J's vaccine next week.